J&J and US government invest $1 billion in COVID-19 vaccineJohnson & Johnson has announced plans to team up with the US government to invest more than $1 Share XJ&J and US government invest $1 billion in COVID-19 vaccinehttps://pharmaphorum.com/news/jj-and-us-government-invest-1-billion-in-covid-19-vaccine/
Pharma giants including Novartis collaborate on COVID-19 therapiesA consortium of life sciences companies including pharma giants such as Novartis and Johnson & Johnson, are to Share XPharma giants including Novartis collaborate on COVID-19 therapieshttps://pharmaphorum.com/news/collaborate-covid19-therapies/
Janssen files MS pill, ahead of FDA decision on BMS’ rivalJanssen has filed its ponesimod pill with the FDA for treatment of adults with relapsing multiple sclerosis, days Share XJanssen files MS pill, ahead of FDA decision on BMS’ rivalhttps://pharmaphorum.com/news/janssen-files-ms-pill-ahead-of-fda-decision-on-bms-rival/
Janssen antibody could be lung cancer breakthroughThe FDA thinks a dual-target antibody from Janssen could set new standards in treatment for certain patients with Share XJanssen antibody could be lung cancer breakthroughhttps://pharmaphorum.com/news/janssen-genmab-antibody-could-be-lung-cancer-breakthrough/
BMS/AbbVie’s combo falls short in untreated multiple myeloma trialAdding Bristol-Myers Squibb/AbbVie’s Empliciti to Revlimid, developed by BMS’ recently acquired Celgene unit, does not improve survival in Share XBMS/AbbVie’s combo falls short in untreated multiple myeloma trialhttps://pharmaphorum.com/news/bms-abbvies-combo-falls-short-in-untreated-multiple-myeloma-trial/
Pharma staff told to work at home as Biogen deals with coronavirus outbreakThe coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked Share XPharma staff told to work at home as Biogen deals with coronavirus outbreakhttps://pharmaphorum.com/news/biogen-deals-with-staff-coronavirus-outbreak/
GSK’s Walmsley gets £2.5m pay rise after strong 2019There can’t be many people in the UK who enjoyed a £2.5 million pay rise this year – Share XGSK’s Walmsley gets £2.5m pay rise after strong 2019https://pharmaphorum.com/news/gsks-walmsley-gets-2-5m-pay-rise-after-strong-sales/
Takeda and Arcturus join hunt for coronavirus therapiesThe Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for Share XTakeda and Arcturus join hunt for coronavirus therapieshttps://pharmaphorum.com/news/takeda-and-arcturus-join-hunt-for-coronavirus-therapies/
J&J’s Apple Watch-based atrial fibrillation study recruits patientsApple and Johnson & Johnson have begun enrolling patients in a study that will investigate whether the Apple Share XJ&J’s Apple Watch-based atrial fibrillation study recruits patientshttps://pharmaphorum.com/news/jjs-apple-watch-based-atrial-fibrillation-study-recruits-patients/
